Ascendis Pharma Stock Forecast - Naive Prediction

ASND Stock  USD 129.81  7.17  5.85%   
The Naive Prediction forecasted value of Ascendis Pharma AS on the next trading day is expected to be 111.86 with a mean absolute deviation of 5.17 and the sum of the absolute errors of 315.31. Ascendis Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Ascendis Pharma stock prices and determine the direction of Ascendis Pharma AS's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Ascendis Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, Ascendis Pharma's Payables Turnover is projected to increase slightly based on the last few years of reporting. The current year's Receivables Turnover is expected to grow to 9.25, whereas Asset Turnover is forecasted to decline to 0.20. . As of November 22, 2024, Common Stock Shares Outstanding is expected to decline to about 39.2 M. The current year's Net Loss is expected to grow to about (498.6 M).

Ascendis Pharma Cash Forecast

Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Ascendis Pharma's financial statements to predict how it will affect future prices.
 
Cash  
First Reported
2013-12-31
Previous Quarter
258.7 M
Current Value
258.7 M
Quarterly Volatility
221.5 M
 
Yuan Drop
 
Covid
A naive forecasting model for Ascendis Pharma is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Ascendis Pharma AS value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Ascendis Pharma Naive Prediction Price Forecast For the 23rd of November

Given 90 days horizon, the Naive Prediction forecasted value of Ascendis Pharma AS on the next trading day is expected to be 111.86 with a mean absolute deviation of 5.17, mean absolute percentage error of 42.08, and the sum of the absolute errors of 315.31.
Please note that although there have been many attempts to predict Ascendis Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Ascendis Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Ascendis Pharma Stock Forecast Pattern

Backtest Ascendis PharmaAscendis Pharma Price PredictionBuy or Sell Advice 

Ascendis Pharma Forecasted Value

In the context of forecasting Ascendis Pharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Ascendis Pharma's downside and upside margins for the forecasting period are 108.50 and 115.21, respectively. We have considered Ascendis Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
129.81
108.50
Downside
111.86
Expected Value
115.21
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Ascendis Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Ascendis Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria121.85
BiasArithmetic mean of the errors None
MADMean absolute deviation5.169
MAPEMean absolute percentage error0.0396
SAESum of the absolute errors315.3073
This model is not at all useful as a medium-long range forecasting tool of Ascendis Pharma AS. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Ascendis Pharma. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Ascendis Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ascendis Pharma AS. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
119.37122.64125.91
Details
Intrinsic
Valuation
LowRealHigh
86.2689.53134.90
Details
Bollinger
Band Projection (param)
LowMiddleHigh
121.09126.13131.18
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.89-1.8-1.53
Details

Other Forecasting Options for Ascendis Pharma

For every potential investor in Ascendis, whether a beginner or expert, Ascendis Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ascendis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ascendis. Basic forecasting techniques help filter out the noise by identifying Ascendis Pharma's price trends.

Ascendis Pharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ascendis Pharma stock to make a market-neutral strategy. Peer analysis of Ascendis Pharma could also be used in its relative valuation, which is a method of valuing Ascendis Pharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Ascendis Pharma AS Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Ascendis Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Ascendis Pharma's current price.

Ascendis Pharma Market Strength Events

Market strength indicators help investors to evaluate how Ascendis Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ascendis Pharma shares will generate the highest return on investment. By undertsting and applying Ascendis Pharma stock market strength indicators, traders can identify Ascendis Pharma AS entry and exit signals to maximize returns.

Ascendis Pharma Risk Indicators

The analysis of Ascendis Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ascendis Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ascendis stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ascendis Pharma AS is a strong investment it is important to analyze Ascendis Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ascendis Pharma's future performance. For an informed investment choice regarding Ascendis Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Ascendis Pharma to cross-verify your projections.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ascendis Pharma. If investors know Ascendis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ascendis Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.86)
Revenue Per Share
5.595
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.28)
Return On Equity
(8.18)
The market value of Ascendis Pharma AS is measured differently than its book value, which is the value of Ascendis that is recorded on the company's balance sheet. Investors also form their own opinion of Ascendis Pharma's value that differs from its market value or its book value, called intrinsic value, which is Ascendis Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ascendis Pharma's market value can be influenced by many factors that don't directly affect Ascendis Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ascendis Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ascendis Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ascendis Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.